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Introduction
Molecular MRI has emerged as a promising, non-invasive
modality to accurately detect high-risk atherosclerotic
plaques. Due to the inherently low sensitivity of MRI, con-
trast agents targeted at an abundant and robust compo-
nent of the lesion are required. Fibrin represents a
clinically relevant target and imaging of aortic, coronary,
carotid and cardiac thrombi have been demonstrated
both in animal models and men. It has been recognised as
an important component of atherosclerotic plaques and is
present throughout plaque development.
Purpose
This study aimed to investigate the feasibility of intra-
plaque fibrin detection throughout plaque development
with EP-2104R, a fibrin targeted contrast agent, in an in
vivo mouse model of progressive atherosclerosis.
Methods
Male C57BL/6 apolipoprotein E-knockout mice (ApoE -/-
) were fed a high fat diet (HFD) for 4, 8 and 12 weeks prior
to MRI of their brachiocephalic artery pre- and post i.v.
administration of EP-2104R. A fourth group of mice were
treated with pravastatin during the 12 week HFD period.
MRI was performed on a 3 T scanner (Philips Achieva,
Best, Netherlands). A cardiac-triggered inversion-recovery
gradient-echo sequence was used for contrast detection.
Both the CNR and T1 relaxation time within the plaques
were determined and compared to the absolute gadolin-
ium concentration measured by inductively coupled mass
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Representative images from (A) pre- EP-2104R in 12 week HFD ApoE -/- mice, and 1.5 - 2 hours after i.v. administration of 10 μmol/kg EP-2104R in (B) week HFD Apoe -/- mice and (C) 12 week HFD ApoE -/- miceFigure 1
Representative images from (A) pre- EP-2104R in 12 week HFD ApoE -/- mice, and 1.5 - 2 hours after i.v. 
administration of 10 μmol/kg EP-2104R in (B) week HFD Apoe -/- mice and (C) 12 week HFD ApoE -/- mice.Page 1 of 2
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spectroscopy (ICP-MS). Histological sections were stained
with MSB for fibrin visualization and compared to MRI.
Results
MRI with EP-2104R significantly enhanced the plaques
(Figure 1) in the brachiocephalic arteries of 4, 8 and 12
week HFD mice compared to their respective non-contrast
enhanced images (P < 0.05), and wild-type control mice
(P < 0.05). Furthermore, plaque CNR and T1 increased
during the HFD and were in good agreement with ICP-
MS. Plaques from the 12 week HFD ApoE -/- mice dis-
played a sudden increase in both CNR and gadolinium
concentration, which is in agreement with spontaneous
plaque rupture as previously reported in this model (P <
0.05). The statin-treated mice had a reduction of CNR as
compared to the 12-week untreated group (Figure 2). His-
tological sections correlated well with the MRI results.
Conclusion
These results demonstrate the feasibility of intraplaque
fibrin detection using EP-2104R. Direct fibrin imaging
could be potentially useful for the detection of vulnerable
coronary atherosclerotic lesions during the development
of disease in vivo, which could aid earlier diagnosis and
intervention.
CNR of plaques within the brachiocephalic arteries with molecular MRI pre- (grey) and 1.5 - 2 ours post (black) i.v. administration of EP-2104R (n = .9)Figure 2
CNR of plaques within the brachiocephalic arteries 
with molecular MRI pre- (grey) and 1.5 - 2 hours post 
(black) i.v. administration of EP-2104R (n = 5.9). All 
EP-2104R treated HFD groups show significant visual 
enhancement of plaques compared to non-contrast enhanced 
images and the control.Page 2 of 2
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